Contents
Download PDF
pdf Download XML
431 Views
358 Downloads
Share this article
Research Article | Volume 4 Issue 2 (July-Dec, 2023)
Histopathological study on importance of Hsp70 as a tumor marker in patients with colorectal adenocarcinoma
 ,
 ,
Under a Creative Commons license
Open Access
Published
Sept. 14, 2023
Abstract
Colorectal cancer (CRC) is the third most common cancer and the fourth most common cause of cancer-related death, with its incidence increasing year by year.The heat-shock protein 70 (Hsp70) is important effectors to protect the intracellular proteins from misfolding or aggregation, also inhibit cell death and signaling cascades that preserve the intracellular signaling pathways which are critical for cell survival. The expression of Hsp70 is frequently abnormally high in cancer cells, they participate in oncogenesis and in resistance to chemotherapy; therefore, the inhibition of Hsp70 has become an interesting strategy in cancer therapy. The aim of the study was to perform histopathological examination and immunohistochmical analysis of paraffin-embedded sections prepared from biopsies taken from colorectal lesions of patients diagnosed with different stages of CRC to show expression of Hsp70 in different stages. Methods: The study involved (146) men and women who were clinically diagnosed with CRC by the general surgery doctor .The patient age range between 36 and 80 years .This study designs as prospective study , all samples were taken from patients in multicenter during the period from December 2021 to December 2022 . Histopathological and immunohistochemical analysis of tissues were performed for 52 patients only. Results: the results showed that Hsp70 expression with CRC moderately differentiated (grade I1) was 59.6% in total staining reaction, followed by the CRC poorly differentiated (grade III) 24.9% , while CRC (grade I) the expressions of (Hsp70) have been reported (7.69% ) respectively. According to the staging of CRC, the study included 5 patients with stage I, (15) patients with stage II, 23 patients with stage III and 9 patients with stage IV. The reaction for Hsp70 expression in (stage I) was weak ( 7.69% ) ,while in( stage II) the weak reaction was (5.7 %),the moderate was ( 17.3% ) , while in the stage III the weak reaction was (3.84) , and the moderate was( 25% ) and strong reaction was (15.3%),while in stage IV the moderate was ( 11.53% ) and strong reaction was (5.7%). Conclusions: The biomarker is aberrantly overexpressed in CRC and high expression of Hsp70 biomarker induced by associated with high grades of CRC , in contrast the low expression level associated with low grade of CRC.
Keywords
Advertisement
Recommended Articles
Research Article
Role of Hydroxychloroquine Therapy in COVID 19 Patients. A Systematic Review and Meta Analysis
...
Published: 30/05/2022
Download PDF
Original Article
Role of Audits in Helathcare associated Infections
Published: 20/06/2024
Download PDF
Research Article
Hyperlipidemia is a Risk Factor for Patients Suffering from Thrombophlebitis: A Finding from an Analytical Cross-Sectional Study Conducted in a Medical College in the Foothills of Western Himalayas
Published: 10/10/2022
Download PDF
Research Article
Exploring Public Awareness of Eating Disorders Among Adolescents in District Solan: A Study on Anorexia and Bulimia
Published: 30/07/2024
Download PDF
Chat on WhatsApp
Flowbite Logo
Najmal Complex,
Opposite Farwaniya,
Kuwait.
Email: kuwait@iarcon.org

Editorial Office:
J.L Bhavan, Near Radison Blu Hotel,
Jalukbari, Guwahati-India
Useful Links
Order Hard Copy
Privacy policy
Terms and Conditions
Refund Policy
Others
About Us
Contact Us
Online Payments
Join as Editor
Join as Reviewer
Subscribe to our Newsletter
Follow us
MOST SEARCHED KEYWORDS
scientific journal
 | 
business journal
 | 
medical journals
 | 
Scientific Journals
 | 
Academic Publisher
 | 
Peer-reviewed Journals
 | 
Open Access Journals
 | 
Impact Factor
 | 
Indexing Services
 | 
Journal Citation Reports
 | 
Publication Process
 | 
Impact factor of journals
 | 
Finding reputable journals for publication
 | 
Submitting a manuscript for publication
 | 
Copyright and licensing of published papers
 | 
Writing an abstract for a research paper
 | 
Manuscript formatting guidelines
 | 
Promoting published research
 | 
Publication in high-impact journals
Copyright © iARCON Internaltional LLP . All Rights Reserved.